JODIE LOCKHART

Issues related to Medicare policies impacting ESRD; Medicare Secondary Payer Act - HR 6860; ESRD Prospective Payment System; value-based care and alternative payment models; home dialysis; H.R.5074 - Kidney PATIENT Act

Issues related to Medicare policies impacting ESRD; Medicare Secondary Payer Act - HR 6860; ESRD Prospective Payment System; value-based care and alternative payment models; home dialysis; H.R.5074 - Kidney PATIENT Act

Issues related to Medicare policies impacting ESRD; Medicare Secondary Payer Act - HR 6860; ESRD Prospective Payment System; value-based care and alternative payment models; home dialysis; H.R.5074 - Kidney PATIENT Act

Issues related to Medicare policies impacting ESRD; Medicare Secondary Payer Act - HR 6860; ESRD Prospective Payment System; value-based care and alternative payment models; home dialysis; H.R.5074 - Kidney PATIENT Act

Issues related to Medicare policies impacting ESRD; Medicare Secondary Payer Act - H.R. 6860/S.5018; ESRD Prospective Payment System; value-based care and alternative payment models; home dialysis

Issues related to Medicare policies impacting ESRD; Medicare Secondary Payer Act - H.R. 6860/S.5018; ESRD Prospective Payment System; value-based care and alternative payment models; home dialysis

Issues related to Medicare policies impacting ESRD; Medicare Secondary Payer Act - H.R. 6860/S.5018; ESRD Prospective Payment System; value-based care and alternative payment models; home dialysis

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Issues related to Medicare policies impacting ESRD; Medicare Secondary Payer Act - H.R. 6860/S.5018; ESRD Prospective Payment System; value-based care and alternative payment models; home dialysis

Issues related to Medicare policies impacting ESRD; Medicare Secondary Payer Act - H.R. 6860/S.5018; ESRD Prospective Payment System; value-based care and alternative payment models; home dialysis

Issues related to Medicare policies impacting ESRD; Medicare Secondary Payer Act - H.R. 6860/S.5018; ESRD Prospective Payment System; value-based care and alternative payment models; home dialysis

Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R. 1805, Leos Law.

Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R. 1805, Leos Law.

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R. 1805, The Rare Disease Clinical Trials Pandemic Disruption Act. Reauthorization of the Pandemic and All-Hazards Preparedness Act.

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; Medicare Part D redesign; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R. 1805, The Rare Disease Clinical Trials Pandemic Disruption Act. Reauthorization of the Pandemic and All-Hazards Preparedness Act. H.R. 2673, The American Innovation and R&D Competitiveness Act.

Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R. 1805, Leos Law.

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; Medicare Part D redesign; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R. 1805, The Rare Disease Clinical Trials Pandemic Disruption Act. Reauthorization of the Pandemic and All-Hazards Preparedness Act. H.R. 2673, The American Innovation and R&D Competitiveness Act.

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R. 1805, The Rare Disease Clinical Trials Pandemic Disruption Act. Reauthorization of the Pandemic and All-Hazards Preparedness Act.

Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R. 1805, Leos Law.

Policies and regulations impacting drugs for rare diseases and conditions; pharmaceutical pricing issues; 340B; Safe Step Act - HR 2630/S 652; FTC regulation of biopharma mergers and acquisitions

Policies and regulations impacting drugs for rare diseases and conditions; pharmaceutical pricing issues; 340B; Safe Step Act - HR 2630/S 652

Value-based pricing arrangements; MVP Act - HR 2666

Value-based pricing arrangements; MVP Act - HR 2666

Value-based pricing arrangements; MVP Act - HR 2666

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; Medicare Part D redesign; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R. 1805, The Rare Disease Clinical Trials Pandemic Disruption Act. Reauthorization of the Pandemic and All-Hazards Preparedness Act. H.R. 2673, The American Innovation and R&D Competitiveness Act.

Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R. 830, S.1375, The HELP Copays Act. H.R. 5539, The ORPHAN Cures Act.

Issues related to Medicare policies impacting ESRD; Medicare Secondary Payer Act - HR 6860; ESRD Prospective Payment System; value-based care and alternative payment models; home dialysis

Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R. 830, S.1375, The HELP Copays Act. H.R. 5539, The ORPHAN Cures Act.

Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R. 830, S.1375, The HELP Copays Act

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R. 830, S.1375, The HELP Copays Act

Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R. 830, S.1375, The HELP Copays Act. H.R. 5539, The ORPHAN Cures Act.

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Policies and regulations impacting drugs for rare diseases and conditions; pharmaceutical pricing issues; 340B; Safe Step Act - HR 2630/S 652

Policies and regulations impacting drugs for rare diseases and conditions; pharmaceutical pricing issues; 340B; Safe Step Act - HR 2630/S 652; FTC regulation of biopharma mergers and acquisitions

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;

Policies and regulations impacting drugs for rare diseases and conditions; pharmaceutical pricing and supply chain issues; Safe Step Act - HR 2163/S 464

Policies and regulations impacting drugs for rare diseases and conditions; pharmaceutical pricing and supply chain issues; 340B Drug Pricing Program, Safe Step Act - HR 2163/S 464

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;

issues related to pharmaceutical reimbursement; H.R. 3

issues related to pharmaceutical reimbursement; H.R. 3

Issues related to Medicare coverage of Radiology Assistants; HR3657, Medicare Access to Radiology Care Act

Issues related to Medicare coverage of Radiology Assistants; HR3657, Medicare Access to Radiology Care Act

Issues related to Medicare coverage of Radiology Assistants; HR3657, Medicare Access to Radiology Care Act

issues related to pharmaceutical reimbursement of research and development expenses; FY2022 Budget Reconciliation/Inflation Reduction Act of 2022 (H.R.5376, P.L.117-169)

issues related to pharmaceutical reimbursement; FY2022 Budget Reconciliation/Inflation Reduction Act of 2022 (H.R.5376, P.L.117-169)

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;

Medicare beneficiary access to innovative medical technologies; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 5818/S 3132, Outpatient Surgery Quality and Access Act

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;

Value-based pricing arrangements; pharmaceutical pricing issues; HR 7389, MVP Act

Issues related to medical device servicing and remanufacturing; reauthorization of the Medical Device User Fee Program (HR 7667/S 4348)

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;

Issues related to medical device servicing and remanufacturing; reauthorization of the Medical Device User Fee Program (HR 7667/S 4348)

Issues related to medical device servicing and remanufacturing; reauthorization of the Medical Device User Fee Program (HR 7667/S 4348)

Issues related to Medicare policies impacting ESRD; charitable premium assistance; integrated kidney care; alternative payment models; Medicare Advantage; home dialysis; telehealth; ESRD Prospective Payment System; Medicare Secondary Payer; Restore Protections for Dialysis Patients Act - HR 8594/S 4750

Issues related to Medicare policies impacting ESRD; telehealth; HR 8594/S 4750, Restore Protections for Dialysis Patients Act; PAYGO

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;